Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Bullboard Posts
Comment by valentinemassonon Aug 12, 2020 7:34pm
210 Views
Post# 31400835

RE:When I see pro pumpers...

RE:When I see pro pumpers...MIR has 680 million shares out and 110 million warrants. Sona has 60 million shares out. Many here hold in excess of 100 thousand shares and if held, lessens the float greatly. Pro pumpers are expected in any stock in a situation like this one. Ignore button works great.With the posting of jobs, rwvwnue in an FDA recognized CLIA lab, situated on US soil forming new partnerships, making a mark and coming on radar, over 24 million trades today alone and the launch of Aristotle by eoy, it is very unlikely this will sink.
PlumpGrumpTrump wrote: ...like that OneBigNewz guy show up, I'm a little wary. This could very well be yet another purely speculative run. These guys appear exactly in those circumstances and then vanish when their profit is cashed in. That 30M volume overall is reassuring but still, I'm very, very cautious about what's happening right now. Happy but cautious. 

And maybe you guys should go easy with the MIR and SONA comparisons. Both these stocks are not bloated pigs like SZLS is. I have no doubt that we will go up if we have good test numbers, maybe not as much as those two. 


Bullboard Posts